Rocket Lab Corp

Rocket Lab’s 430 % rally, analyst‑boosted price targets, and 52‑week low raise red flags; investors must weigh the company’s negative P/E and sector volatility before chasing space‑flight hype.

Rocket Lab’s Q1 2026 results reveal a dramatic revenue lift to $200 M, a $2.2 B backlog, and positive EBITDA, marking a shift from high‑risk startup to a mature, growth‑oriented space launch provider poised for larger defense and commercial contract…

Rocket Lab’s booming space business fuels investor interest, thanks to record government contracts, the new Neutron rocket and a focus on reusable tech.

Rocket Lab’s record revenue growth clashes with launch delays, over‑expansion, and a steep negative P/E, leaving investors wary of a shaky market outlook.

Rocket Lab’s Q4 2025 earnings loom: investors eye a potential surge amid a booming commercial launch market, but testing setbacks and a negative P/E flag risk‑taker caution.

Rocket Lab’s Q4 earnings could unlock 30–70% upside, as the company expands launch services, wins defense contracts, and drives near‑900% revenue growth.

Rocket Lab’s 100% 2025 launch success and $816 m defense contract propel its stock to new highs, highlighting a strong growth path in small‑satellite and U.S. space‑defense markets.

Rocket Lab’s stock surges 19% as it gears up to launch JAXA’s RAISE‑4 satellite, positioning the company for new launch vehicles and a growing government portfolio.

Rocket Lab shares climb 19% ahead of its JAXA “Raise & Shine” launch, pushing market cap to $26.4B and fueling investor confidence for the 19th Electron mission.

Rocket Lab Corporation’s stock performance is marked by volatility and valuation challenges, with a negative price-to-earnings ratio and high price-to-book ratio raising questions about the company’s financial health and sustainability in the space …